论文部分内容阅读
该文旨在评估序列放化疗在头颈鳞癌治疗中的可行性和耐受性,明确是否采用诱导化疗联合放疗或同期放化疗,同时对不同年龄头颈鳞癌患者采用序列放化疗的治疗结果进行比较。194例接受顺铂和5-氟尿嘧啶诱导化疗的头颈鳞癌患者符合纳入标准。与诱导化疗相关的死亡率为1.5%。191(98.5%)例患者接受根治性放疗,其中90.1%的患者接受同
The purpose of this article is to evaluate the feasibility and tolerability of chemoradiation in the treatment of squamous cell carcinoma of the head and neck. To determine if induction chemotherapy combined with radiotherapy or concurrent chemoradiotherapy is adopted, and to treat patients with head and neck squamous cell carcinoma at different ages by sequential radiotherapy and chemotherapy Compare 194 patients with cisplatin and 5-fluorouracil-induced chemotherapy for head and neck squamous cell carcinoma met the inclusion criteria. The mortality associated with induction chemotherapy was 1.5%. 191 (98.5%) patients received radical radiotherapy, of which 90.1% of patients received the same